VanbaelenApo SRL
VanbaelenApo reported total assets of 39,958 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 May 2026).
The score of VanbaelenApo shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -72 % Total assets -62 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
VanbaelenApo's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 May 2026
- Year ended 31 Dec 2024filed on 11 Jun 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 03 Aug 2023
- Year ended 31 Dec 2021filed on 19 Jul 2022
VanbaelenApo's financial analysis
- Solvency46.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of VanbaelenApo
VanbaelenApo's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0558.971.507
- VAT number
- BE0558971507
- Peppol
- Registered · 0208:0558971507 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Aug 2014
- Registered office
- 8200 Bruges
- Latest accounts
- 2025 · filed on 08 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
VanbaelenApo (SRL) has been based in Bruges since 2014, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 11,845 € and equity of 18,600 €; its revenue is not published. Its solvency stands at 46.5%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to VanbaelenApo
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- P.Stievanin Partner Solutions Retail sale of pharmaceutical products Binche · balance sheet 39,868 €
- WE Farma Retail sale of pharmaceutical products Oosterzele · balance sheet 39,748 €
- LP Society Retail sale of pharmaceutical products Fontaine-l'Évêque · balance sheet 41,178 €
- APR. Yasmine Michielsen Retail sale of pharmaceutical products Brecht · balance sheet 41,956 €
- ConSaJo Retail sale of pharmaceutical products Stabroek · balance sheet 42,199 €
- PharmAzzy Retail sale of pharmaceutical products Zonhoven · balance sheet 37,787 €
- Apotheker Silke Christiaens Retail sale of pharmaceutical products Lennik · balance sheet 37,111 €
Frequently asked questions about VanbaelenApo
What is the revenue of VanbaelenApo?
VanbaelenApo files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of VanbaelenApo?
In Belgium, the VAT number is the company number prefixed with BE: BE0558971507 for VanbaelenApo, if the company is VAT-registered. Its company number (CBE) is 0558.971.507.
Where is the registered office of VanbaelenApo?
According to the CBE register, the registered office of VanbaelenApo is in 8200 Bruges.
What is the equity of VanbaelenApo?
At the close of the 2025 financial year, the equity of VanbaelenApo amounts to 18,600 €, a solvency of 46.5% of total assets.
Who manages VanbaelenApo?
The register lists 1 active mandates at VanbaelenApo. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of VanbaelenApo
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →